Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 8OTHER 4UNKNOWN 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 2Neoplasms 1Cancer Pain 1

Interventions

S 1 (combination) 7Cisplatin 7Radiotherapy, Intensity-Modulated 5Paclitaxel 5Oxaliplatin 3Irinotecan 3Capecitabine 3titanium silicide 2raltitrexed 2nimotuzumab 2nabiximols 2Radiotherapy 2Radiation Dose Hypofractionation 2pegylated granulocyte colony-stimulating factor 1nedaplatin 1icaritin 1gimeracil 1anlotinib 1Trastuzumab 1Temozolomide 1Tegafur 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Pemetrexed 1Ondansetron 1Methylene Blue 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × UNKNOWN × nabiximols × Clear all
NCT01262651 2018-04-23

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

GWPharm

Phase 3 Completed
397 enrolled 18 charts

Cancer Pain, Pain

NCT00530764 2013-06-20

SPRAY

GWPharm

Phase 2 Completed
360 enrolled 18 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡